Lenalidomide Market

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Lenalidomide Market contains market size and forecasts of Lenalidomide in global, including the following market information:

• Global Lenalidomide Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Lenalidomide Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Lenalidomide companies in 2021 (%)

The global Lenalidomide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5 mg Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lenalidomide include Celgene and SL Pharma etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lenalidomide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lenalidomide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Lenalidomide Market Segment Percentages, by Type, 2021 (%)

• 5 mg Capsules
• 10 mg Capsules
• 15 mg Capsules
• 25 mg Capsules

Global Lenalidomide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Lenalidomide Market Segment Percentages, by Application, 2021 (%)

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

Global Lenalidomide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Lenalidomide Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Lenalidomide revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Lenalidomide revenues share in global market, 2021 (%)
• Key companies Lenalidomide sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Lenalidomide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Celgene
• SL Pharma